| View |
|
DR-XY45648
|
Beclometasone dipropionate + Formoterol fumarate
dihydrate
|
Foster Nexthaler
|
100 mcg/6 mcg per
|
Actuation Powder for Inhalation
|
Anti-asthma (Adrenergic-Corticosteroid Combination)
|
Chiesi Farmaceutici S.P.A
|
Italy
|
Initial
|
28 March 2022
|
08 November 2026
|
| View |
|
DR-XY45650
|
Ambroxol hydrochloride
|
Zerrutussin
|
15mg/ 5mL
|
Syrup
|
Mucolytic
|
Pharmatechnica Laboratory, Inc.
|
Philippines
|
Automatic Renewal
|
22 October 2021
|
22 November 2026
|
| View |
|
DR-XY45651
|
Ambroxol hydrochloride
|
Zerrutussin
|
30mg/ 5mL
|
Syrup
|
Mucolytic
|
Pharmatechnica Laboratory, Inc.
|
Philippines
|
Automatic Renewal
|
29 November 2021
|
22 November 2026
|
| View |
|
DR-XY45653
|
Febuxostat
|
Feburic
|
80 mg
|
Film-Coated Tablet
|
-
|
Sanofi-Aventis De Mexico, S.A. De C.V.
|
Mexico
|
Initial [from Monitored Release]
|
11 January 2023
|
28 November 2026
|
| View |
|
DR-XY45658
|
Cefuroxime (as Sodium)
|
Zinox
|
750mg
|
Powder for Solution for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Zhuhai United Laboratories (Zhongshan) Co., Ltd.
|
China
|
Automatic Renewal
|
04 March 2022
|
22 November 2026
|
| View |
|
DR-XY45661
|
Gabapentin
|
Neuran
|
300mg
|
Capsule
|
-
|
Hovid Berhad
|
Malaysia
|
-
|
30 June 2021
|
22 November 2026
|
| View |
|
DR-XY45662
|
Esomeprazole (as sodium)
|
Peprazom IV
|
40mg
|
Powder for Solution for Injection (IV)
|
Proton Pump Inhibitor
|
Laboratorios Normon, SA
|
Spain
|
Renewal
|
29 July 2021
|
28 November 2026
|
| View |
|
DR-XY45663
|
Finasteride
|
Monastar
|
1mg
|
Film-Coated Tablet
|
Testosterone-5-alpha reductase inhibitor
|
JW Pharmaceutical Corporation
|
Korea
|
Automatic Renewal
|
21 January 2022
|
22 November 2026
|
| View |
|
DR-XY45664
|
Finasteride
|
Finiod
|
5mg
|
Film-Coated Tablet
|
Testosterone-5-alpha reductase inhibitor
|
JW Pharmaceutical Corporation
|
Korea
|
Automatic Renewal
|
07 December 2021
|
22 November 2026
|
| View |
|
DR-XY45665
|
Pemetrexed (as disodium)
|
None
|
500mg
|
Lyophilized Powder for Solution for IV Infusion
|
Antineoplastic Agent
|
Zydus Hospira Oncology Pvt. Ltd.
|
India
|
Automatic Renewal
|
21 December 2021
|
10 November 2026
|
| View |
|
DR-XY45666
|
Pemetrexed (as disodium)
|
None
|
100mg
|
Lyophilized Powder for Solution for IV Infusion
|
Antineoplastic Agent
|
Zydus Hospira Oncology Pvt. Ltd.
|
India
|
Automatic Renewal
|
04 January 2022
|
10 November 2026
|
| View |
|
DR-XY45667
|
Ascorbic Acid
|
Economed AD-C
|
500 mg
|
Capsule
|
Vitamin
|
Gruppo Medica Inc.
|
Philippines
|
Automatic Renewal
|
12 June 2023
|
10 November 2028
|
| View |
|
DR-XY45668
|
Ascorbic acid (as Sodium Ascorbate)
|
Ascorbex
|
500mg
|
Capsule
|
Vitamin
|
Pharmatechnica Laboratory, Inc.
|
Philippines
|
Renewal
|
18 August 2021
|
10 November 2026
|
| View |
|
DR-XY45670
|
Ascorbic Acid (Vitamin C)
|
None
|
100mg/5mL
|
Syrup
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
29 November 2021
|
10 November 2026
|
| View |
|
DR-XY45671
|
Paracetamol
|
Param
|
10 mg/mL (1 g/100 mL)
|
Solution for Injection (IV Infusion)
|
Analgesic/Antipyretic
|
AMN Life Science Pvt. Ltd.
|
India
|
Automatic Renewal
|
23 September 2021
|
10 November 2026
|
| View |
|
DR-XY45675
|
Clobetasol propionate
|
None
|
500 mcg/g (0.05% w/w)
|
Cream
|
Topical Corticosteroid
|
M.C.B. Dermatological Products
|
Philippines
|
Automatic Renewal
|
30 January 2022
|
15 November 2026
|
| View |
|
DR-XY45676
|
Acetylcysteine
|
Acetimax
|
600mg
|
Effervescent Tablet (Orange Flavor)
|
Mucolytic
|
Scitech Specialties Pvt. Ltd.
|
India
|
Automatic Renewal
|
18 September 2021
|
15 November 2026
|
| View |
|
DR-XY45679
|
Tafluprost
|
Taflotan-S
|
15 mcg/mL (0.0015% w/v))
|
Ophthalmic Solution
|
-
|
Santen Pharmaceutical Co., Ltd. (Noto Plant)
|
Japan
|
Initial (from Monitored Release)
|
09 February 2023
|
08 December 2026
|
| View |
|
DR-XY45681
|
Paracetamol
|
None
|
250mg/ 5mL
|
Oral Suspension (Orange Flavor)
|
Analgesic / Antipyretic
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
12 October 2021
|
28 November 2026
|
| View |
|
DR-XY45684
|
Tiotropium (as bromide) + Olodaterol (as hydrochloride)
|
Spiolto Respimat
|
2.5 mcg/ 2.5 mcg per puff
|
Solution for Oral
Inhalation
|
Bronchodilator (Adrenergic in combination with
Anticholinergic)
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release (MR) status)
|
19 May 2022
|
25 November 2026
|